Global Human Immunodeficiency Virus (HIV) Diagnosis Market Performance Report: Global Trends 2026–2030
Uncover key drivers, emerging technologies, and competitive movements shaping the human immunodeficiency virus (hiv) diagnosis market from 2026–2035 with trusted insights from The Business Research Company
What level of CAGR-driven expansion is anticipated in the Human Immunodeficiency Virus (HIV) Diagnosis Market between 2026 and 2030?
The human immunodeficiency virus (hiv) diagnosis market has seen substantial growth in recent times. Its valuation is anticipated to increase from $4.67 billion in 2025 to $5.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.0%. The expansion observed historically can be attributed to the global spread of hiv infections, governmental hiv screening initiatives, the enhanced availability of rapid diagnostic kits, the development of diagnostic laboratory infrastructure, and increasing public health awareness programs.
The human immunodeficiency virus (hiv) diagnosis market is set to experience significant expansion over the next few years, with its valuation expected to climb to $7.4 billion in 2030, reflecting a compound annual growth rate (CAGR) of 9.3%. This projected increase is driven by several factors, including a heightened demand for early HIV detection, the increasing adoption of self-test kits, the spread of point-of-care diagnostic technologies, a growing emphasis on HIV prevention and ongoing monitoring, and increased financial commitments in infectious disease diagnostics. Noteworthy trends anticipated during this period include a greater embrace of rapid and point-of-care HIV testing, an increased focus on early and routine HIV screening, a rising inclination towards self-testing and home-based diagnostics, the expansion of integrated HIV testing and counseling services, and an intensified commitment to data-driven HIV surveillance and reporting.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp
What Drivers Are Affecting Demand-Supply Dynamics In The Human Immunodeficiency Virus (HIV) Diagnosis Market?
The anticipated rise in blood donation is projected to stimulate the expansion of the HIV diagnosis market in the future. Blood donation refers to the voluntary practice of providing blood through phlebotomy, a procedure involving the insertion of a needle into a vein to collect blood. The increase in blood donations is a result of progress in medical technology, greater community participation, and refined strategies for recruiting and retaining donors. With a higher number of individuals donating blood, a more extensive collection of samples becomes available for HIV testing. This increased access to blood samples allows for more exhaustive screening for HIV antibodies or antigens, thereby improving the accuracy and reliability of HIV diagnosis. For instance, NHS Blood and Transplant, a UK-based government agency, increased the number of new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. As a result, the growing trend of blood donation is propelling the growth of the HIV diagnosis market.
How Is The Human Immunodeficiency Virus (HIV) Diagnosis Market Organized Into Various Segments?
The human immunodeficiency virus (hiv) diagnosis market covered in this report is segmented –
1) By Product: Consumables, Instruments, Software, Services
2) By Mode: Self-Test, Lab-Based
3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions
Subsegments:
1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits), Reagents And Chemicals, Sample Collection Devices (Blood Collection Tubes, Lancets), Test Strips, Control And Calibration Kits, Disposable Gloves And Safety Equipment
2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers), Hiv Viral Load Testing Equipment, Cd4 Count Analyzers, Point-Of-Care Hiv Diagnostic Devices, Molecular Diagnostic Instruments ( Pcr Machines), Electrochemical And Optical Hiv Detection Instruments
3) By Software: Hiv Diagnosis Data Management Software, Electronic Health Record (Ehr) Integration Software, Hiv Test Result Interpretation Software, Laboratory Information Management Systems (Lims), Patient Monitoring And Tracking Software, Cloud-Based Hiv Diagnostic Reporting Tools
4) By Services: Diagnostic Testing Services, Hiv Testing Support Services ( Counseling, Education), Diagnostic Lab Services, Telemedicine And Remote Hiv Testing Services, Clinical Trial Services For Hiv Diagnostic Tests, Data Analytics And Interpretation Services For Hiv Testing
What Upcoming Trends Are Likely To Define The Future Path Of The Human Immunodeficiency Virus (HIV) Diagnosis Market?
Companies operating within the human immunodeficiency virus (HIV) diagnosis market are concentrating on developing durable and highly effective prevention and treatment methods, improving accessibility through supportive reimbursement programs, and advancing innovative clinical strategies to enhance adherence and decrease new HIV infections. For example, in June 2025, Gilead Sciences, a US-based healthcare company, obtained FDA approval for Yeztugo (lenacapavir), which is the first and only twice-yearly injectable PrEP option, representing a significant breakthrough in HIV prevention. Supported by Phase 3 PURPOSE 1 and PURPOSE 2 data, the drug exhibited exceptional efficacy, with ≥99.9% of participants remaining HIV-negative. This long-acting injection aims to address barriers like adherence issues, stigma, and limited awareness that hinder current PrEP adoption. Yeztugo’s approval presents a promising resource for reducing new HIV infections across various populations. Gilead is also enacting comprehensive access measures, including collaborations with insurance companies, co-pay assistance for eligible patients, and free access for uninsured individuals via assistance programs.
Who Are The Core Companies Influencing Trends In The Human Immunodeficiency Virus (HIV) Diagnosis Market?
Major companies operating in the human immunodeficiency virus (hiv) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Molecular Diagnostics, Atila BioSystems Inc.
Access The Complete Report For Deeper Market Insights:
Which Region Is Expected To Experience The Fastest Growth In The Human Immunodeficiency Virus (HIV) Diagnosis Market?
North America was the largest region in the HIV diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (hiv) diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Human Immunodeficiency Virus (HIV) Diagnosis Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15587&type=smp
Browse Through More Reports Similar to the Global Human Immunodeficiency Virus (HIV) Diagnosis Market 2026, By The Business Research Company
Autoimmune Disease Diagnosis Market Report 2026
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
Infectious Disease Diagnostics Testing Market Report 2026
Syphilis Immunoassay Diagnostics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
